Location History:
- Rohovot, IL (2016)
- Rechovot, IL (2017 - 2021)
Company Filing History:
Years Active: 2016-2021
Title: Naamit Sher: Innovator in Anti-Angiogenic Therapies
Introduction
Naamit Sher is a prominent inventor based in Rechovot, Israel. He has made significant contributions to the field of medical research, particularly in the development of anti-angiogenic therapies. With a total of 5 patents to his name, Sher is recognized for his innovative approaches to enhancing treatment efficacy.
Latest Patents
Among his latest patents, Sher has developed methods for inducing responsiveness to anti-angiogenic agents. His invention provides methods of inducing or improving responsiveness to a VEGF antagonist in a subject or a subject population. This involves administering an adenovirus that contains a nucleic acid construct comprising a F AS-chimera gene, which is operably linked to an endothelial cell-specific promoter, alongside the VEGF antagonist. This groundbreaking work aims to improve patient outcomes in cancer therapies.
Career Highlights
Sher's career is marked by his dedication to advancing medical science through innovative research. His work at Vascular Biogenics Ltd. has positioned him as a key player in the development of therapies that target vascular growth in tumors. His research has the potential to change the landscape of cancer treatment.
Collaborations
Some of his notable coworkers include Erez Feige and Eyal Breitbart, who have collaborated with him on various projects within the company. Their combined expertise contributes to the innovative environment at Vascular Biogenics Ltd.
Conclusion
Naamit Sher's contributions to the field of anti-angiogenic therapies highlight his role as a leading inventor in medical research. His innovative methods and dedication to improving treatment efficacy continue to inspire advancements in cancer therapies.